0000950170-24-015205.txt : 20240214
0000950170-24-015205.hdr.sgml : 20240214
20240214160518
ACCESSION NUMBER: 0000950170-24-015205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240212
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tousignant Jennifer
CENTRAL INDEX KEY: 0002010978
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36483
FILM NUMBER: 24637708
MAIL ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BLDG. 17, SUITE 401
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viridian Therapeutics, Inc.\DE
CENTRAL INDEX KEY: 0001590750
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 471187261
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1215
BUSINESS ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BLDG. 17, SUITE 401
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 617.272.4600
MAIL ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BLDG. 17, SUITE 401
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: MIRAGEN THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20170213
FORMER COMPANY:
FORMER CONFORMED NAME: MIRAGEN THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20170213
FORMER COMPANY:
FORMER CONFORMED NAME: SIGNAL GENETICS, INC.
DATE OF NAME CHANGE: 20140710
4
1
ownership.xml
4
X0508
4
2024-02-12
0001590750
Viridian Therapeutics, Inc.\DE
VRDN
0002010978
Tousignant Jennifer
C/O VIRIDIAN THERAPEUTICS, INC.
221 CRESCENT STREET, SUITE 401
WALTHAM
MA
02453
false
true
false
false
Chief Legal Officer
false
Stock Option (Right to Buy)
19.68
2024-02-12
4
A
false
290000
0.00
A
2034-02-12
Common Stock
290000
290000
D
The option vests as to 25% on February 12, 2025 and then in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service to Issuer through each vesting date.
/s/ Jennifer Tousignant
2024-02-14